Compound dual-channel nervonic acid product for preventing and treating encephalopathy as well as preparation method and application thereof

A dual-channel, nervonic acid technology, used in food preparation, application, nervous system diseases, etc., can solve the problems of limited efficacy and single type, and achieve the effect of overcoming adverse reactions, comprehensive effects, and no toxic side effects.

Inactive Publication Date: 2013-09-11
崔晓廷
View PDF3 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] In order to solve the existing technical problems of single types of products for preventing and treating encephalopathy and limited curative effect, one of the purposes

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound dual-channel nervonic acid product for preventing and treating encephalopathy as well as preparation method and application thereof
  • Compound dual-channel nervonic acid product for preventing and treating encephalopathy as well as preparation method and application thereof
  • Compound dual-channel nervonic acid product for preventing and treating encephalopathy as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Example 1: A dual-channel product for preventing and treating encephalopathy, its preparation method and application

[0046] (1) Formula: Ingot maple seed oil (containing 5.8% nervous acid) 45kg, commercially available phosphatidylserine (containing 50% phosphatidylserine) 5kg, vitamin E80g, made into 100,000 capsules, eating method: 3 times a day, each time 2-3 capsules.

[0047] (2) Preparation method

[0048] (a) Ingredients: Weigh ingot maple seed oil, phosphatidylserine and vitamin E, put them in the ingredients tank, and stir evenly;

[0049] (b) Grinding and degassing: Grind the material weighed in step (a) three times with a colloid mill, pass through an 80-mesh sieve, and then place it in a vacuum pot to control the vacuum degree -0.06Mpa to remove the gas in the material ;

[0050] (c) Production of capsule material: weigh gelatin, glycerin, and water in a ratio of 100:40:100, deliver them to a plastic tank, stir and heat up to 75°C, wait until the gelatin...

Embodiment 2

[0058] Example 2: A dual-channel product for preventing and treating encephalopathy and its preparation method and application

[0059] (1) Formula: pentagon maple seed oil (containing 4.9% nervous acid) 46kg, commercially available phosphatidylserine (containing phosphatidylserine 60%) 4kg, vitamin E 80g, made into 100,000 capsules. Edible method: 3 times a day, 2-3 capsules each time.

[0060] (2) The preparation method is the same as in Example 1.

[0061] (3) Application

[0062] Application of the above-mentioned dual-channel encephalopathy prevention and treatment product in the preparation of products for the treatment of cranial nerve diseases, including sequelae of cerebral apoplexy, senile dementia, Parkinson's disease, cerebral palsy, cerebral atrophy, traumatic cranial nerve injury, Memory loss and brain fatigue.

Embodiment 3

[0063] Example 3: A dual-channel product for preventing and treating encephalopathy and its preparation method and application

[0064] (1) Formula: bitter tea maple seed oil (containing 7.1% nervous acid) 25kg, commercially available phosphatidylserine (containing phosphatidylserine 60%) 25kg, vitamin E 80g, made into 100,000 capsules. Edible method: 3 times a day, 2-3 capsules each time.

[0065] (2) The preparation method is the same as in Example 1.

[0066] (3) Application

[0067] Application of the above-mentioned dual-channel encephalopathy prevention and treatment product in the preparation of products for the treatment of cranial nerve diseases, including sequelae of cerebral apoplexy, senile dementia, Parkinson's disease, cerebral palsy, cerebral atrophy, traumatic cranial nerve injury, Memory loss and brain fatigue.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a dual-channel product for preventing and treating encephalopathy. The product comprises nervonic acid and phosphatidylserine according to the mass ratio of being (1-9):(1-9). The preparation method comprises the following steps: (a) compounding according to the mass ratio of raw materials; (b) grinding and degassing; (c) preparing a capsule material; (d) pelleting; (e) molding and drying; (f) pellet washing; (g) selecting and screening; (h) packaging. The invention further discloses an application of the dual-channel product in the preparation of a product for treating a cranial nerve disease. The product can be used for synchronously treating cranial nerve cells and nerve fibers, thereby taking a comprehensive effect on the encephalopathy and having an obvious effect. In addition, the product is natural purely and safe to eat, and can be absorbed completely as well as cannot generate toxic and side effects. The preparation method is reasonable in process and strong in operability, thereby being suitable for large-scale industrial production.

Description

Technical field: [0001] The invention relates to a compound nervous acid product for preventing and treating encephalopathy with two pathways, a preparation method and application thereof. Background technique: [0002] According to epidemiological surveys, brain infarction, cerebral hemorrhage, brain atrophy, cerebral dementia, cerebral palsy in children, epilepsy, Parkinson's disease, traumatic brain injury and other nerve-damaging encephalopathy account for about 30% of the total number of human diseases. Moreover, diseases such as cerebral infarction also have the characteristics of "four highs" of high morbidity, high mortality, high disability, and high recurrence rate. There are nearly 10 million new cases of encephalopathy each year in my country, of which the death and disability rate accounts for about 75%. The country and patients spend tens of billions of dollars on encephalopathy treatment. [0003] In the prevention and treatment of encephalopathy, so far the...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/685A61P25/00A61P25/28A61P25/16A23L1/302A61K31/201A61K31/355A23L33/15
Inventor 王悦崔晓廷
Owner 崔晓廷
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap